<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="9745">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01680705</url>
  </required_header>
  <id_info>
    <org_study_id>SIESS-2012</org_study_id>
    <nct_id>NCT01680705</nct_id>
  </id_info>
  <brief_title>Ideal Frequency of Postoperative High Volume Saline Irrigations Following Endoscopic Sinus Surgery</brief_title>
  <official_title>Ideal Frequency of Postoperative High Volume Saline Irrigations Following Endoscopic Sinus Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dr. Luke Rudmik</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Calgary</source>
  <oversight_info>
    <authority>Canada: Ethics Review Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to determine what the ideal frequency of high-volume sinonasal
      saline irrigation in the early postoperative period following ESS for medically refractory
      CRS.  We will evaluate once, twice, and three times daily frequency sinonasal saline
      irrigation protocols. Our hypothesis is that three times a day sinonasal saline irrigations
      for the first week is ideal with no difference between frequencies after 1 week.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Chronic Rhinosinusitis (CRS) is a common inflammatory condition of the upper respiratory
      tract lasting more than 8 to 12 weeks.  Major symptoms include facial congestion/fullness,
      facial pain/pressure, nasal obstruction/blockage, purulent nasal drainage, and reduction or
      loss of smell.  The diagnosis must include two major symptoms and either endoscopic evidence
      of polyps, edema or mucopurulent discharge from the middle meatus and/or CT changes in the
      mucosa of sinuses or ostiomeatal complexes.

      CRS has an estimated prevalence of 5% in the Canadian population, and up to 16% in some
      adult populations in the United States.  Sinusitis is associated with a major societal
      health care burden, costing billions of dollars a year in North America. The medical
      treatment of CRS includes topical saline and corticosteroid sprays, systemic steroids and
      antimicrobials.  Specifically, sinonasal saline irrigation is a safe, nonpharmacologic
      treatment, and an important and efficacious component in the management of CRS.  Sinonasal
      saline irrigation can vary by concentration (e.g. hypertonic, isotonic, hypotonic), pressure
      (e.g. passive or active), and volume (e.g. high and low).

      A recent evidence-based review by Rudmik et al. recommended sinonasal saline irrigation in
      the early postoperative period following endoscopic sinus surgery. Although 'daily'
      sinonasal saline irrigations are recommended, the ideal frequency is unknown since there
      have been no studies evaluating this topic.

      This is a prospective, randomized, single blind study evaluating the subjective and
      objective outcomes of different sinonasal saline irrigation frequencies in patients who
      receive ESS for medically refractory CRS.  Both disease-specific quality of life (QoL) and
      endoscopy scores will be measured at 1 week, 3 weeks, and 2 months postoperatively.  The
      expected total number of patients to be enrolled in this study is approximately 75 (25 per
      arm), with a planned completion time of two years.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2012</start_date>
  <completion_date type="Anticipated">September 2014</completion_date>
  <primary_completion_date type="Anticipated">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Change in Quality of Life</measure>
    <time_frame>Pre and post operative (1, 3 and 8 weeks post operatively)</time_frame>
    <safety_issue>No</safety_issue>
    <description>The SNOT-22 and the nasal and sinus symptoms score will be complete by the patient to assess quality of life. They will be completed preoperatively and 1 week, 3 weeks and 2 months postoperatively.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Endoscopic Score</measure>
    <time_frame>Pre and Post-Operative (1, 3 and 8 weeks post operatively)</time_frame>
    <safety_issue>No</safety_issue>
    <description>Two endoscopic scales (the Lund-Kennedy and the POSE) will be used to assess the endoscopic appearance pre and post operatively. They will be completed preoperatively and 1 week, 3 weeks and 2 months postoperatively.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Rhinosinusitis</condition>
  <arm_group>
    <arm_group_label>Frequency: Once Daily</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will use high volume saline irrigation once daily post operatively.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Frequency: Twice Daily</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will use high volume saline irrigation twice daily post operatively.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Frequency: Three Times Daily</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will use high volume saline irrigation three times daily post operatively.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High Volume Saline Irrigation</intervention_name>
    <description>High volume saline irrigation (240 ml)</description>
    <arm_group_label>Frequency: Once Daily</arm_group_label>
    <arm_group_label>Frequency: Twice Daily</arm_group_label>
    <arm_group_label>Frequency: Three Times Daily</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients with a diagnosis of CRS as per guidelines (&gt; 18 years old)

          -  Documented failed medical treatment of CRS

          -  Planned ESS for the treatment of CRS

          -  Able to read and understand English

        Exclusion Criteria:

          -  Pregnant

          -  Cystic Fibrosis

          -  Diagnosed immotile cilia syndrome

          -  Diagnosed immunodeficiency syndrome

          -  Diagnosed fungal sinusitis

          -  Sinonasal tumours or obstructive lesions
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Luke Rudmik, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Calgary</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Luke Rudmik, MD</last_name>
    <email>lukerudmik@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kristine Smith, MD</last_name>
    <phone>587-228-3391</phone>
    <email>kasmi@ucalgary.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Calgary</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luke Rudmik, MD</last_name>
      <email>lukerudmik@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Kristine Smith, MD</last_name>
      <phone>587-228-3391</phone>
      <email>kasmi@ucalgary.ca</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <reference>
    <citation>Chen Y, Dales R, Lin M. The epidemiology of chronic rhinosinusitis in Canadians. Laryngoscope. 2003 Jul;113(7):1199-205.</citation>
    <PMID>12838019</PMID>
  </reference>
  <reference>
    <citation>Anand VK. Epidemiology and economic impact of rhinosinusitis. Ann Otol Rhinol Laryngol Suppl. 2004 May;193:3-5. Review.</citation>
    <PMID>15174752</PMID>
  </reference>
  <reference>
    <citation>Ray NF, Baraniuk JN, Thamer M, Rinehart CS, Gergen PJ, Kaliner M, Josephs S, Pung YH. Healthcare expenditures for sinusitis in 1996: contributions of asthma, rhinitis, and other airway disorders. J Allergy Clin Immunol. 1999 Mar;103(3 Pt 1):408-14.</citation>
    <PMID>10069873</PMID>
  </reference>
  <reference>
    <citation>Van Cauwenberge P, Watelet JB. Epidemiology of chronic rhinosinusitis. Thorax. 2000 Oct;55 Suppl 2:S20-1. Review.</citation>
    <PMID>10992549</PMID>
  </reference>
  <reference>
    <citation>Tomooka LT, Murphy C, Davidson TM. Clinical study and literature review of nasal irrigation. Laryngoscope. 2000 Jul;110(7):1189-93.</citation>
    <PMID>10892694</PMID>
  </reference>
  <reference>
    <citation>Rabago D, Zgierska A, Mundt M, Barrett B, Bobula J, Maberry R. Efficacy of daily hypertonic saline nasal irrigation among patients with sinusitis: a randomized controlled trial. J Fam Pract. 2002 Dec;51(12):1049-55.</citation>
    <PMID>12540331</PMID>
  </reference>
  <reference>
    <citation>Morley AD, Sharp HR. A review of sinonasal outcome scoring systems - which is best? Clin Otolaryngol. 2006 Apr;31(2):103-9. Review.</citation>
    <PMID>16620328</PMID>
  </reference>
  <reference>
    <citation>Wright ED, Agrawal S. Impact of perioperative systemic steroids on surgical outcomes in patients with chronic rhinosinusitis with polyposis: evaluation with the novel Perioperative Sinus Endoscopy (POSE) scoring system. Laryngoscope. 2007 Nov;117(11 Pt 2 Suppl 115):1-28.</citation>
    <PMID>18075447</PMID>
  </reference>
  <reference>
    <citation>Hopkins C, Browne JP, Slack R, Lund V, Brown P. The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict? Otolaryngol Head Neck Surg. 2007 Oct;137(4):555-61.</citation>
    <PMID>17903570</PMID>
  </reference>
  <verification_date>September 2012</verification_date>
  <lastchanged_date>September 11, 2012</lastchanged_date>
  <firstreceived_date>August 30, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Calgary</investigator_affiliation>
    <investigator_full_name>Dr. Luke Rudmik</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Chronic Rhinosinusitis</keyword>
  <keyword>Endoscopic Sinus Surgery</keyword>
  <keyword>Sinonasal saline irrigation</keyword>
  <keyword>Frequency</keyword>
  <keyword>Postoperative</keyword>
  <keyword>High Volume</keyword>
  <keyword>Randomized Control Trial</keyword>
  <keyword>Single Blinded</keyword>
  <keyword>Prospective Study</keyword>
  <keyword>Quality of Life</keyword>
  <keyword>Endoscopic Sinus Score</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Sinusitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
